News from lightlake therapeutics inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Jul 30, 2014, 08:30 ET

Lightlake Therapeutics Inc. Receives Funding Commitment From A Prominent International Research And Development Foundation

 Lightlake Therapeutics Inc. ("Lightlake") (OTCQB: LLTP), a biopharmaceutical company developing addiction treatments based on its expertise in...

Jul 23, 2014, 08:30 ET

Lightlake Therapeutics Inc. Files Investigational New Drug Application For Naloxone Nasal Spray For Reversing Opioid Overdose And Announces A Further Collaboration With The National Institute On Drug Abuse

 Lightlake Therapeutics Inc. ("Lightlake") (OTCQB: LLTP), a biopharmaceutical company developing addiction treatments based on its expertise in...

Jul 09, 2014, 08:30 ET

Lightlake Therapeutics Inc. Signs Agreement With Commercial Contract Manufacturer For Its Opioid Overdose Reversal Treatment

Lightlake Therapeutics Inc. ("Lightlake") (OTCQB: LLTP), a biopharmaceutical company developing addiction treatments based on its expertise in...

May 22, 2014, 08:30 ET

Lightlake Therapeutics Inc. To Present At The Third Annual Marcum MicroCap Conference

 Lightlake Therapeutics Inc. ("Lightlake") (OTC BB: LLTP), a biopharmaceutical company developing addiction treatments based on its expertise...

Dec 20, 2013, 09:00 ET

Lightlake Therapeutics Inc. Chief Executive Officer Letter to Shareholders

 Lightlake Therapeutics Inc. ("Lightlake" or the "Company") (OTC BB: LLTP), a biopharmaceutical company developing addiction treatments based...

Dec 03, 2013, 16:05 ET

Initial Data from Lightlake Therapeutics Joint Clinical Trial with NIDA Shows Nasal Delivery of Naloxone for Opioid Overdose as a Promising Treatment

 Lightlake Therapeutics Inc. ("Lightlake" or the "Company") (OTC BB: LLTP), a biopharmaceutical company developing addiction treatments based...

Nov 20, 2013, 09:00 ET

Lightlake Therapeutics to Present at 6th Annual LD MICRO Conference

 Lightlake Therapeutics Inc. ("Lightlake" or the "Company") (OTC BB: LLTP), a biopharmaceutical company developing addiction treatments based...

Sep 24, 2013, 08:30 ET

Lightlake Therapeutics Commences Two-Week Patient Trial for Treatment of Opioid Overdose with National Institute on Drug Abuse (NIDA)

Lightlake Therapeutics Inc. ("Lightlake" or the "Company") (OTC BB: LLTP), a biopharmaceutical company developing addiction treatments based on its...

Aug 21, 2013, 08:30 ET

Lightlake Therapeutics Announces Partnership with National Institute on Drug Abuse (NIDA) to Treat Opioid Overdose

 Lightlake Therapeutics Inc., ("Lightlake" or the "Company") (OTC BB: LLTP), a biopharmaceutical company developing addiction treatments based...

Aug 05, 2013, 09:00 ET

Lightlake Therapeutics Retains KCSA Strategic Communications as Corporate Communications Advisors

 Lightlake Therapeutics Inc., ("Lightlake" or the "Company") (OTC BB: LLTP), a biopharmaceutical company developing addiction treatments based...

Nov 29, 2012, 14:10 ET

Lightlake Therapeutics Appoints Board Member as New Chief Financial Officer

Lightlake Therapeutics Inc. (LLTP) (the "Company" or "Lightlake"), an early stage biopharmaceutical company developing modern addiction treatments...

Sep 24, 2012, 08:00 ET

Lightlake Therapeutics Appoints Dr. David Kessler as Strategic Advisor

Lightlake Therapeutics Inc. (OTCBB: LLTP) (the "Company" or "Lightlake"), an early stage biopharmaceutical company developing modern addiction...

Aug 08, 2012, 08:30 ET

Lightlake Therapeutics Inc. Announces Positive Final Phase II Clinical Trial Results of Binge Eating Disorder Treatment

Lightlake Therapeutics Inc. (OTCBB: LLTP) (the "Company" or "Lightlake"), an early stage biopharmaceutical company developing modern addiction...

May 03, 2012, 09:00 ET

Lightlake Therapeutics Inc. Announces Positive Preliminary Phase II Clinical Trial Results of Binge Eating Disorder Treatment

Lightlake Therapeutics Inc. (OTCBB: LLTP) (the "Company" or "Lightlake"), an early stage biopharmaceutical company developing addiction treatments,...

Jan 06, 2012, 09:00 ET

Lightlake Therapeutics Inc. to Apply Company's Patented Technology in the Development of Premenstrual Syndrome Overeating Treatment

 Lightlake Therapeutics Inc. (OTCBB: LLTP - News) (the "Company" or "Lightlake"), an early stage biopharmaceutical company developing...

Dec 03, 2009, 12:42 ET

Lightlake Therapeutics Inc Receives Ethical Approval to Begin Subject Selection for Future Phase II Clinical Trial for New Obesity Drug, in Helsinki, Finland

After two decades of scientifically and medically proven success in their field, Lightlake Therapeutics' experts have been granted ethical approval...

Dec 03, 2009, 03:00 ET

Lightlake Therapeutics Inc Receives Ethical Approval to Begin Subject Selection for Future Phase II Clinical Trial for New Obesity Drug, in Helsinki, Finland

After two decades of scientifically and medically proven success in their field, Lightlake Therapeutics' experts have been granted ethical approval...